InnovAge Stock Falls Sharply on 10 Million Share Secondary Offering

Shares of InnovAge (NASDAQ: INNV) fell 9.5% in after-hours trading after the company disclosed a significant secondary stock offering by its largest shareholders.

Details of the Offering

Investment funds affiliated with private equity firms Apax Partners and Welsh, Carson, Anderson & Stowe are launching an underwritten public offering of 10 million shares of InnovAge common stock, according to the announcement. The selling stockholders have also granted the underwriters a 30-day option to purchase up to an additional 1.5 million shares.

Critically, this is a secondary offering, meaning InnovAge itself will not receive any proceeds from the sale. The transaction allows the private equity funds to liquidate a portion of their holdings. While the company will not receive capital, it will bear the associated costs of the offering, excluding underwriting discounts and commissions. Barclays, Goldman Sachs, and Wells Fargo are acting as managers for the deal.

Market Impact and Context

Ad

Large secondary offerings by major institutional or private equity investors are often viewed negatively by the market. Such sales can signal that key backers are reducing their exposure, creating a significant supply of new shares—often referred to as a supply overhang—that can pressure the stock price.

The sell-off appeared entirely company-specific. During the regular trading session, the S&P 500 was flat while the Nasdaq Composite gained 0.7%, indicating no broader market pressure was responsible for InnovAge's after-hours decline.

The announcement comes as InnovAge navigates a mixed financial picture. The company's recent Q4 fiscal 2026 earnings report featured revenue of approximately $262 million, which surpassed consensus estimates, but its earnings per share fell slightly short of expectations. The stock was already trading significantly below its 52-week high of $12.64.